Rare diseases
Investigational molecules
Locations
Safety and Tolerability of AZD4956 Alone or with Saruparib in Adults with Advanced Metastatic Solid Tumors (Phase I/IIa)
SpainA study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation
AustriaStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
AustriaStudy of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer
AustriaA study to evaluate the safety and effectiveness of AZD9750 and saruparib in patients with metastatic prostate cancer
The NetherlandsA Study of Saruparib for Patients with Metastatic Pancreatic Cancer with Homologous Repair Deficiency as First Treatment
FranceStudy of Saruparib in Patients with Advanced or Recurrent Ovarian Cancer to Assess Safety and Effectiveness
ItalyStudy on the Safety and Effects of AZD5305 with Hormonal Agents for Patients with Metastatic Prostate Cancer
ItalyStudy of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
